Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
AcadSci, alkaline, alloxinized, ambient, analytical, Andrew, API, array, arrhythmia, ASCO, Biscayne, bleeding, booked, Bostyr, branded, Buffalo, CA, cardian, Carryforward, Ccompany, commensurate, compelling, composed, Contraindicated, crizotinib, Dalton, DE, diagnosed, Diplomate, discovering, drip, Dry, Dupont, duration, EMSO, endocrine, entirety, erythropoietin, EU, exacerbating, exluded, expansion, facilitate, gravity, hERG, Hill, homeostatic, immaterial, impellent, imputed, infusion, instable, interfere, inventory, ionizing, IP, IPS, islet, Jefferson, Klosterneuburg, laureate, Lenox, Maitre, mandated, media, membrane, narrow, navigate, neoplastic, nilotinib, Nobel, operandi, overly, parasitic, PAW, penetration, people, Peter, Pink, pioneering, poorly, precipitate, precursor, prolongation, prolonging, QTc, rabbit, relationship, relegated, robust, Salzburg, Sami, Schally, Schiff, secretion, sit, solubilized, Sordillo, Sorosa, specialty, Spectroscopy, spice, sum, supervision, territory, Threat, timeline, transferred, transparency, Ultrafast, undergoing, unintended, Univ, unreported, unstable, yearly
Removed:
ab, absorbed, Acad, achieved, activate, activated, activating, activation, actively, acute, Adaptor, addressing, Aggarwal, agreeable, Ahn, AKT, Alabama, alpha, alter, Anand, antioxidant, ap, Appendix, approach, Arniban, Asian, assay, assignment, attractive, attributed, autoimmune, automatic, BB, belong, bind, Biocompatible, Biophysical, blockade, blocking, bloodstream, bortezomib, Brairteh, Brookwood, Burro, carcinoma, cascade, cerebral, chemopreventive, chemoresistance, chemoresistence, chemosensitivity, CIP, circulation, clearance, cohort, collaboration, collateral, commencement, confer, conferring, content, conventional, correlated, country, credited, cytotoxic, death, decreased, deducted, degenerative, demographic, depot, detectable, dosing, downstream, economically, Elevated, enabled, encapsulate, encapsulated, envision, exchangeable, executed, execution, expired, explaining, extreme, fatal, feasible, fee, field, fit, focal, Fox, gastrointestinal, Guha, half, hepatocellular, hereinafter, highest, Hydrophobic, Ib, implicated, inactivated, increment, induce, inducted, inflammation, inhibit, inhibition, injected, injection, innate, inspected, intestinal, introduce, invasion, invented, involvement, jointly, jurisdiction, Keshamouni, kidney, Kunnumakkara, layer, leverage, ligand, localized, London, malaria, Medzitof, memory, Michael, migration, Mol, movement, murine, nanoparticle, Notwithstanding, nticancer, obligated, output, oxidative, participation, passage, pegylated, percent, PG, pharmacological, positioned, Predicated, presence, preventive, prime, problem, producing, proliferation, proliferative, promoting, prosecute, protean, protected, publically, quantify, quantity, quotient, radio, RC, Recently, receptor, Reddy, remain, remuneration, renewed, represent, revealed, role, room, routinely, running, Rusian, Schouten, Sci, Serial, serum, Seth, Sethi, shipped, shorten, shown, simultaneously, situ, skeletal, skin, Smart, span, specificity, spite, SRA, stable, stated, step, stomach, stop, subcontinent, sublicense, sublicensee, sublicensing, suggested, suggesting, Sung, surface, Surveillance, survive, survivin, susceptibility, Tentative, thalidomide, ther, title, traditional, transmitted, treat, treating, tumeric, turn, uncontrolled, upfront, Vatsala, VG, waiver, Western, Wolzt
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 Employment Agreement Dated As of February 20, 2013 Between the Registrant and DR. Lawrence Helson
- 10.12 Placement Agency Agreement Dated As of March 5, 2013 by and Between Signpath Pharma Inc. and Meyers Associates L.P.
- 31.1 Certification of the Chief Executive Officer and Chief Financial Officer Pursuant to Rule 13A-14(A) or Rule 15D-14(A), As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002.
- 32.1 Certificate of the Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- Download Excel data file
- View Excel data file
Signpath Pharma similar filings
Filing view
External links